Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€5.05
19.04.21
€3.90
19.04.22
-3.86%
28.05.21

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
DraftKings Inc.

Start price
Target price
Perf. (%)
€46.76
19.04.21
€32.00
19.04.22
-10.00%
28.05.21

Could be worthwhile Investment >10% per year
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.10
19.04.21
€5.00
19.04.22
9.03%
03.05.21

Could be worthwhile Investment >10% per year
buy
Inotiv Inc.

Start price
Target price
Perf. (%)
€17.38
19.04.21
€20.00
19.04.22
14.28%
03.05.21

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.50
19.04.21
€15.00
19.04.22
29.41%
03.05.21

Could be worthwhile Investment >10% per year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.74
19.04.21
€3.00
19.04.22
7.47%
03.05.21

Could be worthwhile Investment >10% per year
buy
Leonardo Ui

Start price
Target price
Perf. (%)
€173.95
19.04.21
€200.00
19.04.22
-6.43%
20.04.22

Could be worthwhile Investment >10% per year
buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€4.40
19.04.21
€6.00
19.04.22
-2.27%
03.05.21

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.62
19.04.21
€4.00
19.04.22
3.82%
03.05.21

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.80
19.04.21
€10.00
19.04.22
-16.67%
03.05.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€6.68
19.04.21
€8.00
19.04.22
18.26%
03.05.21

Could be very worthwhile Investment >20% year
buy
HUYA Inc

Start price
Target price
Perf. (%)
€15.45
19.04.21
-
19.04.22
-75.02%
20.04.22

Innovative
Good culture
buy
Tesla Inc

Start price
Target price
Perf. (%)
€201.90
19.04.21
-
19.04.22
55.69%
20.04.22

Good culture
Could be very worthwhile Investment >20% year
buy
Europcar Mobility Group S.a.

Start price
Target price
Perf. (%)
€0.079
19.04.21
€0.10
-
22.10.22

Could be worthwhile Investment >10% per year
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€14.64
19.04.21
-
19.04.22
-68.10%
20.04.22

Could be very worthwhile Investment >20% year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.78
19.04.21
-
19.04.22
-58.32%
20.04.22

Could be very worthwhile Investment >20% year
buy
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.10
19.04.21
-
19.04.22
-76.52%
20.04.22

Could be very worthwhile Investment >20% year
buy
Aumann AG

Start price
Target price
Perf. (%)
€12.10
19.04.21
-
19.04.24
31.07%
11.03.24

Could be worthwhile Investment >10% per year
buy
Aareal Bank AG

Start price
Target price
Perf. (%)
€23.36
19.04.21
-
19.04.24
37.50%
30.05.22

Could be worthwhile Investment >10% per year
buy
Ms Industrie AG

Start price
Target price
Perf. (%)
€1.69
19.04.21
-
19.04.24
12.43%
11.03.24

Could be worthwhile Investment >10% per year
buy
Itochu Corp.

Start price
Target price
Perf. (%)
€27.07
19.04.21
-
19.04.24
49.65%
11.03.24

Could be worthwhile Investment >10% per year
buy
Vale S.A.

Start price
Target price
Perf. (%)
€16.10
19.04.21
-
19.04.24
-21.12%
11.03.24

Could be worthwhile Investment >10% per year
buy
Infineon Technologies AG

Start price
Target price
Perf. (%)
€35.61
19.04.21
-
19.04.22
-11.19%
28.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Xinyi Solar Holdings Ltd

Start price
Target price
Perf. (%)
€1.49
19.04.21
€2.00
19.04.22
0.73%
20.04.22

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Fair valuation
Standard Investments for future growth
buy
Play Magnus As

Start price
Target price
Perf. (%)
€2.16
19.04.21
€3.00
19.04.22
-42.69%
20.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
positive Cash Flow expected
Good rating